DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Agile Therapeutics, Inc. (AGRX)
« Back to company indexAGRX Chatter Timeline
Stock Ticker for AGRX
Most Active Tweeters for AGRX
| User | Tweets |
|---|---|
| @LlcBillionaire | 8 |
| @proactive_NA | 3 |
| @BioDonor | 3 |
| @MaisaCorp | 2 |
| @TraderTexMex | 2 |
Recent Tweets for AGRX
 |
@Lucy3370 $agrx said they have $ to last into 4th qtr. PDUFA is Nov. they r going to either have to 1. Sell company 2. Part… https://t.co/rb09wv3DYv May 23rd 2019, 10:05am |
 |
@rogerthat191 $AGRX bought some. Chart ugly. Will look to add more around a buck or lower if mkt craps pants https://t.co/474ArtoK6i May 23rd 2019, 9:05am |
 |
@fda_tracker $AGRX New PDUFA Date 2019-11-16 AGILE THERAPEUTICS INC Link:https://t.co/jkcHc0gbIe Calendar:https://t.co/sCt1qKoMdr May 23rd 2019, 9:05am |
 |
@MaisaCorp $AGRX Announces FDA Acceptance of the NDA Resubmission of Twirla. FDA Assigns Prescription Drug User Fee Act (P… https://t.co/FKEgoEHT0J May 22nd 2019, 4:05pm |
 |
@AgileTher $AGRX News: #FDA Accepts #Twirla #NDA Resubmission for Review. #PDUFA 11/16/2019. https://t.co/k8aZIuZC1h https://t.co/lOVrtt6DWi May 22nd 2019, 11:05am |
 |
@bulletin_en Sterling Capital Management Upped Its Macquarie Infrastructure Co Tr $MIC Stake; Algorx Pharmaceuticals $AGRX Senti… https://t.co/0tdV7BBUnA May 22nd 2019, 11:05am |
|
@bulletin_en Engineers Gate Manager LP Has Lowered Its Lincoln Natl Ind $LNC Stake; AGILE THERAPEUTICS $AGRX Has 0.46 Sentiment https://t.co/bsqU5HUeAF May 22nd 2019, 11:05am |
 |
@StockNewsNow $AGRX Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla® https://t.co/E35Gm9UNNJ May 22nd 2019, 10:05am |
 |
@Madeforprofit1 $AGRX FDA acceptance news soon $2+++++++++++++=== 100% upside ???? https://t.co/UdQP3Ay3uV May 22nd 2019, 10:05am |
|
@Madeforprofit1 $AGRX FDA acceptance news soon $2+++++++++++?????? https://t.co/0zDDlMy6cS May 22nd 2019, 10:05am |
 |
@SwingTradeBot 50 DMA Resistance today: $AGRX ... https://t.co/mnYaiRq1wk May 22nd 2019, 9:05am |
 |
@TradeSmartStock $AGRX Big news this morning... volume surge could send this to $2 https://t.co/ipwx8bZS8r May 22nd 2019, 9:05am |
 |
@tradnews_ RT @OpenOutcrier: $AGRX (+5.7% pre) Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla® - SI https://t.co/xsQYA… May 22nd 2019, 8:05am |
 |
@OpenOutcrier $AGRX (+5.7% pre) Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla® - SI https://t.co/xsQYAMOVSX May 22nd 2019, 8:05am |
 |
@LlcBillionaire $AGRX had good news this morning May 22nd 2019, 8:05am |
 |
@TeamBrazil2015 @TradeSmartStock Trying to grab a few now $AGRX May 22nd 2019, 8:05am |
 |
@proactive_NA $AGRX FDA accepts Agile Therapeutics's new drug application for contraceptive patch Twirla https://t.co/pOd4X5BVwY… https://t.co/fEXx8gWWq8 May 22nd 2019, 7:05am |
 |
@BioDonor RT @TraderTexMex: $AGRX 5 days from submission to acceptance PR. November 16th PDUFA May 22nd 2019, 7:05am |
 |
@BioBreakout $AGRX Agile Therapeutics Says FDA Accepts Twirla NDA, PDUFA November 16, 2019 May 22nd 2019, 7:05am |
 |
@bihan35 RT @BioStocks: $AGRX Announces FDA Acceptance of the NDA Resubmission of Twirla. PDUFA 11/16/19 May 22nd 2019, 7:05am |
 |
@PhilKobi $AGRX 5 Days from submission to acceptance and pdufa assignment. Seems unusually quick response from FDA. What ca… https://t.co/wwVSL0eGXx May 22nd 2019, 7:05am |
 |
@pennystocksusa RT @BioDonor: $AGRX FDA accepts the NDA Resubmission of Twirla https://t.co/3jdD8NOjRD May 22nd 2019, 7:05am |
|
@BioDonor $AGRX FDA accepts the NDA Resubmission of Twirla https://t.co/3jdD8NOjRD May 22nd 2019, 7:05am |
 |
@TraderTexMex $AGRX 5 days from submission to acceptance PR. November 16th PDUFA May 22nd 2019, 7:05am |
 |
@BankTheTrade $AGRX today announced that the U.S. Food and Drug Administration ( FDA ) has accepted for review the Company’s Ne… https://t.co/GlABBTDRRC May 22nd 2019, 7:05am |
 |
@BioStocks $AGRX Announces FDA Acceptance of the NDA Resubmission of Twirla. PDUFA 11/16/19 May 22nd 2019, 7:05am |
 |
@Amp_Trades $AGRX Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla® May 22nd 2019, 7:05am |
 |
@WKRBNews Agile Therapeutics $AGRX Lifted to “Hold” at ValuEngine https://t.co/wLPiQZtqBf #markets May 21st 2019, 7:05am |
 |
@ZolmaxNews Agile Therapeutics’ $AGRX “Buy” Rating Reaffirmed at Maxim Group https://t.co/8vxJ2WSF0F May 21st 2019, 1:05am |
 |
@WeekHerald Agile Therapeutics $AGRX Upgraded to “Hold” at ValuEngine https://t.co/o7dg4SwjaZ May 21st 2019, 12:05am |
|
@LlcBillionaire $AGRX it’s dropping May 20th 2019, 9:05pm |
|
@proactive_NA $AGRX Agile Therapeutics makes all-out push for flagship contraceptive patch Twirla https://t.co/cCBikZMgYK via… https://t.co/PGUdNqoEjt May 20th 2019, 12:05pm |
|
@WeekHerald Agile Therapeutics’ $AGRX “Buy” Rating Reaffirmed at Maxim Group https://t.co/xKw2hs22zf May 20th 2019, 2:05am |
 |
@AmericanBanking Zacks: Brokerages Anticipate Agile Therapeutics Inc $AGRX to Announce -$0.11 Earnings Per Share https://t.co/I7D5c9IsFX #stocks May 19th 2019, 10:05pm |
 |
@TranscriptDaily Brokerages Expect Agile Therapeutics Inc $AGRX Will Announce Earnings of -$0.11 Per Share https://t.co/tLInVnAy2n May 19th 2019, 10:05pm |
|
@LlcBillionaire $AGRX under the 20 MA here on watch May 19th 2019, 12:05pm |
 |
@registrarjourn Agile Therapeutics’ $AGRX Buy Rating Reiterated at Maxim Group https://t.co/C3sdFwJaRi May 19th 2019, 3:05am |
 |
@EnterpriseLeade Agile Therapeutics’ $AGRX Buy Rating Reiterated at Maxim Group https://t.co/8COc3eCjf7 May 19th 2019, 3:05am |
|
@AmericanBanking Agile Therapeutics $AGRX Given Buy Rating at Maxim Group https://t.co/oVh12McKTY #stocks May 18th 2019, 2:05pm |
 |
@dispatchtribune Agile Therapeutics’ $AGRX Buy Rating Reiterated at Maxim Group https://t.co/LBiMSqEV2s May 18th 2019, 2:05pm |
 |
@crusadernz Biotech updates 05/17: $AGRX resubmits Twirla NDA (previous CRLs 2013/2017) $ABBV fails late-stage glioblastoma tr… https://t.co/kVPrkB9YcJ May 17th 2019, 9:05pm |
 |
@HottestStockNow $AGRX Resubmits NDA to the FDA for Its Transdermal Low-Dose Contraceptive Patch Twirla https://t.co/Yi5jUk7UjG May 17th 2019, 8:05pm |
|
@MaisaCorp $AGRX resubmitted to the US Food and Drug Administration a new drug application (NDA) for its product candidate,… https://t.co/BNaBPTiNga May 17th 2019, 4:05pm |
 |
@fintel_io $AGRX / Agile Therapeutics files form 8-K https://t.co/fVrPyJYiLh May 17th 2019, 12:05pm |
|
@fintel_io Also, if you are new to $AGRX here's some background for you https://t.co/y4wXsvLxT2 May 17th 2019, 12:05pm |
 |
@AlAltomari RT @AgileTher: #BREAKING: $AGRX has resubmitted the #NDA for its investigational, once-weekly prescription contraceptive patch Twirla® (AG2… May 17th 2019, 11:05am |
|
@StockNewsNow $AGRX Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twi… https://t.co/UD5mwsGSdD May 17th 2019, 10:05am |
 |
@NewsQuantified $AGRX Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla, stock inclines… https://t.co/jGBTmzDsOL May 17th 2019, 9:05am |
 |
@ooapieceovcandy RT @TraderTexMex: $AGRX Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla® May 17th 2019, 9:05am |
|
@proactive_NA $AGRX Agile Therapeutics resubmits new drug application for Twirla contraceptive patch to FDA… https://t.co/Uq5sV0s7Qb May 17th 2019, 8:05am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.